Active Biotech AB ( (SE:ACTI) ) has issued an announcement.
Active Biotech AB has announced its Annual General Meeting (AGM) scheduled for May 28, 2025, where shareholders will discuss key resolutions including the re-election of board members and auditors, and the decision to carry forward the company’s accumulated loss without distributing dividends. This meeting is significant for stakeholders as it addresses the company’s governance and financial strategy moving forward.
More about Active Biotech AB
Active Biotech AB is a Swedish company operating in the biotechnology industry, focusing on developing pharmaceuticals for the treatment of cancer and autoimmune diseases. The company is headquartered in Lund, Sweden.
YTD Price Performance: -21.43%
Average Trading Volume: 26,358
Technical Sentiment Signal: Strong Buy
Current Market Cap: €9.72M
Find detailed analytics on ACTI stock on TipRanks’ Stock Analysis page.